First Light Asset Management »

Adma Biologics shares owned by First Light Asset Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 1.1M 14.66
2025-06-30 $17M 952k 18.21

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Performant Healthcare Common Stocks (PHLT)
Centessa Pharmaceuticals Common Stocks (CNTA)
Neogenomics Common Stocks (NEO)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Health Catalyst Common Stocks (HCAT)
Palvella Therapeutics Common Stocks (PVLA)
Twist Bioscience Corporation Common Stocks (TWST)
Lenz Therapeutics Common Stocks (LENZ)
Organogenesis Holdings Common Stocks (ORGO)
Atricure Common Stocks (ATRC)
Anaptys Bio Common Stocks (ANAB)
Si-bone Common Stocks (SIBN)
Cidara Therapeutics Common Stocks (CDTX)

View all positions for First Light Asset Management

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Geode Capital Management
Nuveen
Westfield Capital Management Company
Dimensional Fund Advisors
American Century Companies
Thrivent Financial for Lutherans
Citadel Advisors
Capital Research Global Investors
Goldman Sachs Group
Franklin Resources

View all funds holding Adma Biologics